GENE-TRANSFER TECHNOLOGIES FOR THE GENE-THERAPY OF CANCER

被引:0
|
作者
VILE, R
RUSSELL, SJ
机构
[1] UNIV CAMBRIDGE,DEPT HAEMATOL,MRC CTR,CAMBRIDGE CB2 2QH,ENGLAND
[2] UNIV CAMBRIDGE,DEPT HAEMATOL,MRC CTR PTOR ENGN,CAMBRIDGE CB2 2QH,ENGLAND
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene therapy for cancer relies upon the delivery of a therapeutic gene to a target cell population which may comprise either the tumour cells themselves or specific host effector cells with anti-tumour activity. In addition, gene delivery may be targeted directly to the tumour cells in vivo or towards cells explanted from the patient. The precise requirements of the delivery system depend upon the specific therapeutic strategy being used in each case, however, delivery must be accurate, efficient and must result in correctly regulated expression of the gene in only the desired cell type. Equally important, the delivery system must be sale for both the patient and the community as a whole. Here, we summarize the types of gene therapy which have been proposed for the treatment of cancer and review how currently available delivery systems are suited to each of these individual strategies.
引用
收藏
页码:88 / 98
页数:11
相关论文
共 50 条
  • [21] GENE-TRANSFER - A POTENTIAL APPROACH TO GENE-THERAPY FOR SICKLE-CELL DISEASE
    BANK, A
    MARKOWITZ, D
    LERNER, N
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1989, 565 : 37 - 43
  • [22] GENE-TRANSFER INTO HEMATOPOIETIC STEM-CELLS - PROSPECTS FOR HUMAN GENE-THERAPY
    EINERHAND, MPW
    VALERIO, D
    CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1992, 177 : 217 - 235
  • [23] GENE-THERAPY OF HEMOPHILIA-B BY MYOBLAST-MEDIATED GENE-TRANSFER
    YAO, SN
    KURACHI, K
    BLOOD, 1993, 82 (10) : A447 - A447
  • [24] GENE-THERAPY OF CERVICAL-CANCER BY ADENOVIRUS-MEDIATED P53 GENE-TRANSFER
    HAMADA, K
    ZHANG, WW
    ALEMANY, R
    ROTH, JA
    WOLF, J
    MITCHELL, MF
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 421 - 421
  • [25] GENE-TRANSFER AS CANCER-THERAPY
    DRANOFF, G
    MULLIGAN, RC
    ADVANCES IN IMMUNOLOGY, VOL 58, 1995, 58 : 417 - 454
  • [26] OPTIMIZATION OF MYOBLAST-MEDIATED GENE-TRANSFER FOR HEMOPHILIA-B GENE-THERAPY
    WANG, J
    YAO, SN
    SUGAHARA, Y
    TAN, J
    KURACHI, K
    BLOOD, 1994, 84 (10) : A743 - A743
  • [27] GENE-THERAPY OF CANCER - USE OF INTERLEUKIN-2 (IL-2) GENE-TRANSFER IN LOCAL IMMUNOTHERAPY
    BUBENIK, J
    LOTZOVA, E
    ZEUTHEN, J
    BUBENIKOVA, D
    SIMOVA, J
    INDROVA, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1991, 10 (04) : 213 - 220
  • [28] GENE-TRANSFER INTO THE MAMMALIAN KIDNEY - 1ST STEPS TOWARDS RENAL GENE-THERAPY
    BOSCH, RJ
    WOOLF, AS
    FINE, LG
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1419 - 1419
  • [29] GENE-TRANSFER INTO THE MAMMALIAN KIDNEY - 1ST STEPS TOWARDS RENAL GENE-THERAPY
    WOOLF, AS
    BOSCH, RJ
    FINE, LG
    KIDNEY INTERNATIONAL, 1993, 43 : S116 - S119
  • [30] TOWARDS LIVER-DIRECTED GENE-THERAPY - RETROVIRUS MEDIATED GENE-TRANSFER INTO HUMAN HEPATOCYTES
    GROSSMAN, M
    RAPER, S
    WILSON, JM
    HEPATOLOGY, 1991, 14 (04) : A184 - A184